Logo Lanfrica
  • Home
  • Atlas
  • Insights
  • Docs
  • Sign in

© 2026 Lanfrica. All rights reserved. All copyrights of the resources shown on the Lanfrica website belong to the original copyright holders, unless explicitly stated otherwise.

Chikungunya Virus serological cross-reactivity in co-endemic settings: Mechanisms, Diagnostic implications, and epidemiological consequences

Domain:

healthcare

Record type:

paper
Creator:
IkeOluDorFol
Publisher:
GSC
Host:
Chikungunya virus (CHIKV) causes an acute febrile illness with debilitating arthralgia, and serological assays remain central to its diagnosis and surveillance. However, antibody-based results are complicated by cross-reactivity in settings where multiple arboviruses co-circulate. This review distinguishes three related but distinct phenomena affecting CHIKV serology: biological cross-reactivity, arising from genuine antigenic overlap between related viruses; assay-associated non-target reactivity, in which a diagnostic platform generates a positive signal without an established biological relationship between the viruses; and diagnostic misclassification, the downstream epidemiological consequence of conflating the two. Applying this framework to five virus pairs, we find that CHIKV–O'nyong-nyong virus (ONNV), CHIKV–Mayaro virus (MAYV) and CHIKV–Ross River virus (RRV) relationships are supported by shared alphavirus antigenic architecture and, in several studies, by functional cross-neutralisation. By contrast, CHIKV reactivity reported in dengue virus (DENV)- and Zika virus (ZIKV)-associated sera lacks an established biological basis and is better classified as assay-associated non-target reactivity of unresolved mechanism. These distinctions matter: unadjusted seropositivity can inflate or obscure CHIKV transmission estimates, and no single diagnostic platform resolves the problem for every virus pair. We argue that CHIKV diagnosis in co-endemic settings requires a layered strategy: molecular detection during the acute phase, antigenically informed and multiplex serology thereafter, and neutralisation-based confirmation where attribution is critical, combined with cross-reactivity-aware statistical modelling for surveillance. Strengthening assay validation and confirmatory testing, particularly in African settings such as Nigeria where CHIKV, DENV and related alphaviruses circulate together, is essential for improving diagnostic accuracy and epidemiological inference.

Visit

doi.org

Languages

Mubako

Similar

Cross-Reactivity of SARS-CoV-2 Laboratory Diagnostics to Endemic Diseases in Africa: A Diagnostic Accuracy StudyNew Insights on Long-Term Hepatitis B Virus Responses in HIV–Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic SettingsGenomic, epidemiological and digital surveillance of Chikungunya virus in the Brazilian AmazonSerological and Molecular Detection of Chikungunya Virus among Arthritis Patient in Khartoum State, SudanStakeholder engagement and mathematical modelling to inform chikungunya vaccination programmes in endemic and epidemic settingsEpidemiological patterns of hepatitis B virus (HBV) in highly endemic areasr

Cross-Reactivity of SARS-CoV-2 Laboratory Diagnostics to Endemic Diseases in Africa: A Diagnostic Accuracy Study

Background: Serology is a great tool to assess the level of immunity against SARS-CoV

New Insights on Long-Term Hepatitis B Virus Responses in HIV–Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings

Background: WHO treatment guidelines recommend tenofovir plus lamivudine or emtricitab

Genomic, epidemiological and digital surveillance of Chikungunya virus in the Brazilian Amazon

International audience BACKGROUND: Since its first detection in the Caribbean in late

Serological and Molecular Detection of Chikungunya Virus among Arthritis Patient in Khartoum State, Sudan

Background: Chikungunya virus is an arthropod-borne virus belonging to the Togaviridae family and th

Stakeholder engagement and mathematical modelling to inform chikungunya vaccination programmes in endemic and epidemic settings

Introduction: S Despite vaccine availability and potential expansion to younger age groups, evidence

Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areasr

Summary This paper uses meta-analysis of published data and a deterministic mathematical model of h